Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Fuller

Showing results (521-530 of 539) with videos related to

Pageof 54
Sort By:
Cancers|January 11, 2024
Intragenic <i>EGFR::EGFR</i>.E1E8 Fusion (EGFRvIII) in 4331 Solid TumorsLan Zheng, Rajyalakshmi Luthra, Hector A Alvarez, et al.
Journal of the American College of Cardiology|April 23, 2016
Emerging Research Directions in Adult Congenital Heart Disease: A Report From an NHLBI/ACHA Working GroupMichelle Gurvitz, Kristin M Burns, Ralph Brindis, et al.
JCI Insight|July 30, 2020
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restorationMartina Ott, Karl-Heinz Tomaszowski, Anantha Marisetty, et al.
Cancer Research|September 3, 2004
A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumorsLei L Chen, Jonathan C Trent, Elsie F Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2018
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant GliomaFrederick F Lang, Charles Conrad, Candelaria Gomez-Manzano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2020
Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II TrialShiao-Pei Weathers, Marta Penas-Prado, Be-Lian Pei, et al.
The Journal of Clinical Investigation|December 25, 2010
Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastomaFernanda I Staquicini, Michael G Ozawa, Catherine A Moya, et al.
JCI Insight|March 22, 2022
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expressionHinda Najem, Martina Ott, Cynthia Kassab, et al.
Brain Pathology (Zurich, Switzerland)|July 4, 2014
International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and gradingDavid N Louis, Arie Perry, Peter Burger, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 13, 2015
Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic ImpactPratheesh Sathyan, Pascal O Zinn, Anantha L Marisetty, et al.
Pageof 54

Showing results (521-530 of 539) with videos related to

Sort By:
Pageof 54
Cancers|January 11, 2024
Intragenic <i>EGFR::EGFR</i>.E1E8 Fusion (EGFRvIII) in 4331 Solid TumorsLan Zheng, Rajyalakshmi Luthra, Hector A Alvarez, et al.
Journal of the American College of Cardiology|April 23, 2016
Emerging Research Directions in Adult Congenital Heart Disease: A Report From an NHLBI/ACHA Working GroupMichelle Gurvitz, Kristin M Burns, Ralph Brindis, et al.
JCI Insight|July 30, 2020
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restorationMartina Ott, Karl-Heinz Tomaszowski, Anantha Marisetty, et al.
Cancer Research|September 3, 2004
A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumorsLei L Chen, Jonathan C Trent, Elsie F Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2018
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant GliomaFrederick F Lang, Charles Conrad, Candelaria Gomez-Manzano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2020
Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II TrialShiao-Pei Weathers, Marta Penas-Prado, Be-Lian Pei, et al.
The Journal of Clinical Investigation|December 25, 2010
Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastomaFernanda I Staquicini, Michael G Ozawa, Catherine A Moya, et al.
JCI Insight|March 22, 2022
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expressionHinda Najem, Martina Ott, Cynthia Kassab, et al.
Brain Pathology (Zurich, Switzerland)|July 4, 2014
International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and gradingDavid N Louis, Arie Perry, Peter Burger, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 13, 2015
Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic ImpactPratheesh Sathyan, Pascal O Zinn, Anantha L Marisetty, et al.
Pageof 54